Pharmacokinetics of ε-aminocaproic acid in patients undergoing aortocoronary bypass surgery

Anesthesiology

Volumn 90, Issue 6, 1999, Pages 1624-1635

  Butterworth, John ^a   James, Robert L ^b   Lin, Yonggu ^b   Prielipp, Richard C ^b   Hudspeth, Allen S ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Antifibrinolytic therapy; Coronary artery bypass grafting; Coronary artery disease; Fibrinolysis; Pharmacokinetics

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; FEMALE; FIBRINOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; ADOLESCENT; METABOLIC CLEARANCE RATE; MIDDLE AGED;

6-AMINOCAPROIC ACID; ADOLESCENT; AGED; ANTIFIBRINOLYTIC AGENTS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED;

EID: 0032587586     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199906000-00019     Document Type: Article

References (22)

1. Horrow JC: Management of coagulopathy associated with cardio pulmonary bypass, Cardiopulmonary Bypass: Principles and Practice. Edited by Gravlee GP, Davis RF, Utley JR. Baltimore, Williams and Wilkins, 1993, pp 436-66
2. Carr ME Jr: Control of perioperative bleeding: Pharmacologic agents, Pharmacologic Management of Perioperative Bleeding. Edited by Wechsler AS. Southampton, NY, CME Network Publishing, 1996, pp 28-34
3. Lam S: High performance liquid chromatographic assay of Amicar ∈-Aminocaproic acid, in plasma and urine after pre-column derivatization with o-phthalaldehyde for fluorescence detection. Biomed Chromatogr 1990; 4:175-7
4. Davey JF, Ersser RS: Amino acid analysis of physiological fluids by high-performance liquid chromatography with phenylisothiocyanate derivatization and comparison with ion-exchange chromatography. J Chromatogr 1990; 528:9-23
5. Sheiner LB, Beal SL: Pharmacokinetic parameter estimates from several least squares procedures: Superiority of extended least squares. J Pharmacokinet Biopharm 1985; 13:185-201
6. Kotz S, Johnson NL: Schwarz criterion, Encyclopedia of Statistical Sciences, vol. 8. Edited by Kotz S, Johnson NL. New York, John Wiley, 1988, pp 289-90
7. Frederiksen MC, Bowsher DJ, Ruo TI, Henthorn TK, Ts'ao CH, Green D, Atkinson AJ Jr: Kinetics of epsilon-aminocaproic acid distribution, elimination, and antinbrinolytic effects in normal subjects. Clin Pharmacol Ther 1984; 35:387-93
8. Garwood S, Matthew J, Barash PG, Hines R: Reduced blood loss at the expense of renal function: Is epsilon aminocaproic acid a blow to the kidney (abstract)? ANESTHESIOLOGY 1997; 87:A67
9. Pitts TO, Spero JA, Bontempo FA, Greenberg A: Acute renal failure due to high-grade obstruction following therapy with ∈-aminocaproic acid. Am J Kidney Dis 1986; 8:441-4
10. Aprotinin, Physicians' Desk Reference, 52nd Edition. Montvale, NJ, Medical Economics Company, 1998, pp. 631-5
11. McNicol GP, Fletcher AP, Alkjaersig N, Sherry S: The absorption, distribution, and excretion of ∈-aminocaproic acid following oral or intravenous administration to man. J Lab Clin Med 1962; 59:15-24
12. Rosow CE: Pharmacokinetic and pharmacodynamic effects of cardiopulmonary bypass, Cardiopulmonary Bypass: Principles and Practice. Edited by Gravlee GP, Davis RF, Utley JR. Baltimore, Williams and Wilkins, 1993, pp 207-32
13. Slaughter TF, Faghih F, Greenberg CS, Leslie JB, Sladen RN: The effects of ∈-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Anesth Analg 1997; 85:1221-6
14. Bennett-Guerrero E, Sorohan JG, Canada AT, Ayuso L, Newman MF, Reves JG, Mythen MG: ∈-Aminocaproic acid plasma levels during cardiopulmonary bypass. Anesth Analg 1997; 85:248-51
15. Daily PO, Lamphere JA, Dembitsky WP, Adamson RM, Dans NF: Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994; 108:99-108
16. Vander Salm TJ, Ansell JE, Okike ON, Marsicano TH, Lew R, Stephenson WP, Rooney K: The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: A double-blind randomized study. J Thorac Cardiovasc Surg 1988; 95:538-40
17. Vander Salm TJ, Kaur S, Lancey RA, Okike ON, Pezzella AT, Stahl RF, Leone L, Li J-M, Valeri CR, Michelson AD: Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. J Thorac Cardiovasc Surg 1996; 112:1098-107
18. Arom KV, Emery RW: Decreased postoperative drainage with addition of epsilon-aminocaproic acid before cardiopulmonary bypass. Ann Thorac Surg 1994; 57:1108-13
19. DelRossi AJ, Cernaianu AC, Botros S, Lemole GM, Moore R: Prophylactic treatment of postperfusion bleeding using EACA. Chest 1989; 96:27-30
20. Karski JM, Teasdale SJ, Norman PH, Carroll JA, Weisel RD, Glynn MFX: Prevention of postbypass bleeding with tranexamic acid and ∈-aminocaproic acid. J Cardiothorac Vasc Anesth 1993; 7:431-5
21. Dentz ME, Slaughter TF, Mark JB: Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid. ANESTHESIOLOGY 1995; 82:583-6
22. Sinclair J, Forbes CD, Prentice CRM, Scott R: The incidence of deep vein thrombosis in prostatectomized patients following administration of the fibrinolytic inhibitor, aminocaproic acid (EACA). Urol Res 1976; 4:129-31